Phenotypic screening using large-scale genomic libraries to identify drug targets for the treatment of cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Cancer cells acquire oncogenic properties through genetic and non-genetic changes during malignant progression.
• These properties include uncontrolled proliferation, drug resistance, invasiveness, anoikis-resistance, and cancer stemness.
• Large-scale genomic screening has identified potential cancer drug targets but faces reproducibility issues.

Purpose of the Study:

• To summarize recent advances in functional screening for identifying cancer drug target genes.
• To discuss current challenges and limitations in cancer drug target discovery.
• To provide future perspectives on optimizing the identification of novel drug targets.

Main Methods:

• Review of recent literature on functional screening methods for cancer drug target identification.
• Analysis of existing datasets and screening models (in vitro and in vivo).
• Discussion of common issues, including reproducibility and validation of identified targets.

Main Results:

• Functional screening approaches have yielded numerous promising cancer drug target genes.
• Significant challenges remain, particularly concerning the reproducibility and validation of identified targets across different studies.
• The heterogeneity of cancer necessitates diverse screening strategies.

Conclusions:

• Functional screening is crucial for discovering novel cancer drug targets.
• Addressing reproducibility and validation issues is essential for clinical translation.
• Future research should focus on integrated approaches and robust validation to improve cancer drug discovery.